Abstract
"Psychosis" is an umbrella term used in the description of various conditions that involve delusions and hallucinations. This article will focus on the management of schizophrenia. Schizophrenia is a complex disorder, which provides many pharmacotherapy-related challenges. Advances have been made in the treatment of the condition. However, this requires a team approach, with the pharmacist monitoring treatment, both for safety and efficacy. The involvement of medicines that might possibly modulate the N-methyl-D-aspartate receptors is an exciting development that should be monitored. © Medpharm.
Original language | English |
---|---|
Pages (from-to) | 28-33 |
Number of pages | 6 |
Journal | SA Pharmaceutical Journal |
Volume | 81 |
Issue number | 4 |
Publication status | Published - 1 Jan 2014 |
Keywords
- Antipsychotic drugs
- First-generation antipsychotic drugs
- Schizophrenia
- Second-generation antipsychotic drugs